National competition, in collaboration with adMare BioInnovations, demonstrates AbbVie's commitment to a thriving biotech ecosystem in ...
Kalhor recognized for his work developing technologies to aid understanding of how early-life biological signals influence ...
SHANGHAI, SHANGHAI, CHINA, April 30, 2026 /EINPresswire.com/ -- The development of new medicines increasingly depends ...
Chiesi Group (“Chiesi”), an international research-focused biopharmaceutical group and certified B Corp, and KalVista ...
Orchard Therapeutics, a Kyowa Kirin company, announced it has been granted Innovation Passport designation for OTL-201, an investigational haemopoietic stem cell (HSC) gene therapy in development for ...
When we treat cancer patients, their disease can overcome treatment through its innate capacity to adapt. This is at the ...
New approach opens door to better-targeted treatments and faster drug discovery for complex diseases
McGill researchers have developed an AI tool called SIDISH that identifies high-risk cancer cells driving aggressive disease, enabling more precise and targeted treatment strategies. By linking single ...
The field of infectious disease research faces persistent challenges in bridging the gap between laboratory findings and successful clinical translation.
A new treatment for patients with life-threatening infectious diseases is being pioneered in Melbourne by researchers at The ...
Researchers at McMaster University have developed a new generative artificial intelligence (AI) model capable of drastically ...
Gut microbiota research is opening up fresh opportunities for innovative drug discovery and health product innovation, experts said recently in Beijing, as China steps up efforts to foster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results